🇵🇱 Poland Country × Condition
generalized myasthenia gravis Clinical Trials in Poland
Active clinical trials for generalized myasthenia gravis with research sites in Poland. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 3, Phase 2, Phase 3 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇵🇱 Poland
Active Trials in Poland (2)
NCT06607627 Phase 3
Recruiting
PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis
Enrollment
12 pts
Country
🇵🇱 Poland
Alexion Pharmaceuticals, Inc.
View Trial → NCT06392386 Phase 2, Phase 3
Recruiting
A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis
Enrollment
12 pts
Country
🇵🇱 Poland
argenx
View Trial → Frequently Asked Questions
How many generalized myasthenia gravis clinical trials are active in Poland?
There are currently 2 active clinical trials for generalized myasthenia gravis with sites in Poland, of which 2 are actively recruiting patients.
How can I join a generalized myasthenia gravis clinical trial in Poland?
To join a generalized myasthenia gravis clinical trial in Poland, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Poland directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are generalized myasthenia gravis trials in Poland?
Active generalized myasthenia gravis trials in Poland span Phase 3, Phase 2, Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology